AI-generated summary
The authors report a prospective clinical trial of 48 vitiligo patients with 105 patches treated with a 308-nm excimer laser at clinics in Saudi Arabia. Over 75% repigmentation was seen in 60.0% of lesions, and side effects were mild and short-lived. The authors conclude the treatment was effective, safe and improved psychosocial quality of life.
- Participants
- 48
- Who or what was studied
- Forty-eight patients with 105 vitiliginous patches treated at dermatology clinics affiliated with Qassim University, Saudi Arabia
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The abstract describes a single-group prospective trial without a stated control group, and it does not report a limitation statement.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on annsaudimed.net.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.